SPIRA™-A 3D and HCT/p DBM vs. Medtronic Divergent™-L/Perimeter™ and Recombinant BMP-2
Status unconfirmed · Not applicable
Conditions studied: Degenerative Disc Disease, Spinal Stenosis, Spondylolisthesis, Scoliosis
In brief
A prospective, randomized, controlled clinical evaluation utilizing the SPIRA™ ALIF 3-D printed titanium interbody device with DBM vs a Medtronic PEEK ALIF interbody device with BMP
Key facts
- Study ID
- NCT04566874
- Run by
- Camber Spine Technologies
- People needed
- 100
- Starts
- 2020-07-13
- Expected to finish
- 2021-07-01
- Last updated by the study team
- 2020-09-28
Who can join
Age: 22 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- skeletally mature adults
- completed 6 month non-operative or conservative therapy
- signed informed consent
- back pain with radicular symptoms as evidenced by leg pain
- Degenerative Disc Disease involving a single level between L2 and S1
- subject willing to participate in study and follow protocol
- subject willing to comply with Post-op management program
You may not qualify if…
- systemic infection such as AIDS, HIV or Active hepatitis
- autoimmune disease
- significant metabolic disease that might compromise bone growth
- history of malignancy
- previous surgery for primary tumor, trauma or infection
- subject requires 2 or more levels of fusion
- previous spinal instrumentation or previous interbody fusion at involved level
- spondylolisthesis of grade greater than/equal to 2
Where it is running
- Rothman Orthopaedic Institure — Philadelphia, Pennsylvania, United States (enrolling)
- Texas Back Institute — Plano, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.